Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lia Gore

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.
The Lancet. Gastroenterology & Hepatology|July 14, 2019
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A Lowery, Howard A Burris, Filip Janku, et al.
Nature Reviews. Clinical Oncology|January 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancerLiora Schultz, Kevin McNerney, Adam J Lamble, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Journal of Neuropathology and Experimental Neurology|September 2, 2017
Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous CraniopharyngiomaAndrew M Donson, John Apps, Andrea M Griesinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and AdolescentsLucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
Pediatric Blood & Cancer|November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade gliomaKaren D Wright, Xiaopan Yao, Wendy B London, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.
The Lancet. Gastroenterology & Hepatology|July 14, 2019
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A Lowery, Howard A Burris, Filip Janku, et al.
Nature Reviews. Clinical Oncology|January 23, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancerLiora Schultz, Kevin McNerney, Adam J Lamble, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Journal of Neuropathology and Experimental Neurology|September 2, 2017
Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous CraniopharyngiomaAndrew M Donson, John Apps, Andrea M Griesinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and AdolescentsLucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
Pediatric Blood & Cancer|November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade gliomaKaren D Wright, Xiaopan Yao, Wendy B London, et al.
Pageof 12